Skip to main content
Top
Published in: Medical Oncology 2/2012

01-06-2012 | Original Paper

Telomere shortening occurs early during gastrocarcinogenesis

Authors: Yunchuan Mu, Qing Zhang, Linhang Mei, Xiaosun Liu, Weili Yang, Jiren Yu

Published in: Medical Oncology | Issue 2/2012

Login to get access

Abstract

When telomeres are shortened to a critical length, they will initiate chromosomal instability (CIN) and may finally cause tumorigenesis. The purpose of the present study was to evaluate the shortened telomere as a potential biomarker for tumorigenesis in gastric carcinoma. The telomeres in matched cancer and adjacent noncancer mucosa samples from 86 gastric carcinoma patients were measured by real-time polymerase chain reaction (PCR). According to the International Union Against Cancer (UICC), tumor stages were classified into four groups: stage I (n = 23), stage II (n = 20), stage III (n = 23), and stage IV (n = 20). Telomere length decreased with aging in both adjacent noncancer mucosa and cancer tissue (r = −0.261 (P = 0.008) and r = −0.27 (P = 0.012), respectively). The telomere length of UICC stage I tumors was significantly shorter than the average telomere length in adjacent noncancer mucosa (P = 0.023). Telomere length increased gradually with increasing UICC stage (P = 0.032). The telomere length of UICC stage IV tumors was significantly longer, when compared to that in noncancer mucosa (P = 0.019) and stage I tumors (P = 0.002). In summary, telomere length undergoes shortening in early stage gastric carcinoma and lengthening in advanced gastric carcinoma. Additionally, telomere shortening may initiate the tumorigenesis of gastric carcinoma.
Literature
1.
go back to reference Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477–90.PubMedCrossRef Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477–90.PubMedCrossRef
3.
go back to reference Milne AN, Carneiro F, O’Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126(5):615–28.PubMedCrossRef Milne AN, Carneiro F, O’Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126(5):615–28.PubMedCrossRef
4.
go back to reference Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119(5):265–72.PubMedCrossRef Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol. 1993;119(5):265–72.PubMedCrossRef
5.
go back to reference Bornschein J, Kandulski A, Selgrad M, Malfertheiner P. From gastric inflammation to gastric cancer. Dig Dis. 2010;28(4–5):609–14.PubMedCrossRef Bornschein J, Kandulski A, Selgrad M, Malfertheiner P. From gastric inflammation to gastric cancer. Dig Dis. 2010;28(4–5):609–14.PubMedCrossRef
6.
go back to reference Chin L, et al. p53 deficiency rescues the advance effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999;97(4):527–38.PubMedCrossRef Chin L, et al. p53 deficiency rescues the advance effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999;97(4):527–38.PubMedCrossRef
7.
go back to reference Aida J, et al. Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol. 2007;38(8):1192–200.PubMedCrossRef Aida J, et al. Telomere length variations in 6 mucosal cell types of gastric tissue observed using a novel quantitative fluorescence in situ hybridization method. Hum Pathol. 2007;38(8):1192–200.PubMedCrossRef
8.
go back to reference Sobin LH, Wittekind CH. TNM classification of malignant tumors. 6th ed. New York, NY, USA: Wiley; 2002. Sobin LH, Wittekind CH. TNM classification of malignant tumors. 6th ed. New York, NY, USA: Wiley; 2002.
9.
10.
11.
go back to reference Blackbum EH. Structure and function of telomeres. Nature. 1991;350:569–73.CrossRef Blackbum EH. Structure and function of telomeres. Nature. 1991;350:569–73.CrossRef
12.
go back to reference Djojosubroto MW, Choi YS, Lee HW, Rudolph KL. Telomeres and telomerase in aging, regeneration, and cancer. Mol Cells. 2003;15(2):164–75.PubMed Djojosubroto MW, Choi YS, Lee HW, Rudolph KL. Telomeres and telomerase in aging, regeneration, and cancer. Mol Cells. 2003;15(2):164–75.PubMed
13.
go back to reference Furugori E, et al. Telomere shortening in gastric carcinoma with aging despite telomerase activation. J Cancer Res Clin Oncol. 2000;126(8):481–5.PubMedCrossRef Furugori E, et al. Telomere shortening in gastric carcinoma with aging despite telomerase activation. J Cancer Res Clin Oncol. 2000;126(8):481–5.PubMedCrossRef
14.
go back to reference Nakamura K, et al. Correlation of telomere lengths in normal and cancers tissue in the large bowel. Cancer Lett. 2000;158:179–84.PubMedCrossRef Nakamura K, et al. Correlation of telomere lengths in normal and cancers tissue in the large bowel. Cancer Lett. 2000;158:179–84.PubMedCrossRef
15.
go back to reference Gumus-Akay G, et al. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognosyic significance. Genet Mol Res. 2007;6(1):41–9.PubMed Gumus-Akay G, et al. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognosyic significance. Genet Mol Res. 2007;6(1):41–9.PubMed
16.
go back to reference Nakamura Y, Tahara E, Tahara H, Yasui W, Ide T. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog. 1999;16(4):312–20.CrossRef Nakamura Y, Tahara E, Tahara H, Yasui W, Ide T. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog. 1999;16(4):312–20.CrossRef
17.
go back to reference Liu XN, et al. Constitutive telomere length and gastric cancer risk: case–control analysis in Chinese Han population. Cancer Sci. 2009;100(7):1300–5.PubMedCrossRef Liu XN, et al. Constitutive telomere length and gastric cancer risk: case–control analysis in Chinese Han population. Cancer Sci. 2009;100(7):1300–5.PubMedCrossRef
18.
go back to reference Blackburn EH. Telomeres and telomerase: their mechanism of action and the effects of action and the effects of altering their functions. FEBS Lett. 2005;579:859–62.PubMedCrossRef Blackburn EH. Telomeres and telomerase: their mechanism of action and the effects of action and the effects of altering their functions. FEBS Lett. 2005;579:859–62.PubMedCrossRef
19.
go back to reference Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol. 1992;225(4):951–60.PubMedCrossRef Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol. 1992;225(4):951–60.PubMedCrossRef
20.
go back to reference Artandi SE, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–5.PubMedCrossRef Artandi SE, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature. 2000;406:641–5.PubMedCrossRef
21.
go back to reference Cosme-Blanco W, Chang S. Dual roles of telomere dysfunction in initiation and suppression of tumorigenesis. Exp Cell Res. 2008;314:1973–9.PubMedCrossRef Cosme-Blanco W, Chang S. Dual roles of telomere dysfunction in initiation and suppression of tumorigenesis. Exp Cell Res. 2008;314:1973–9.PubMedCrossRef
22.
go back to reference Gertler R, et al. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol. 2004;22:1807–14.PubMedCrossRef Gertler R, et al. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol. 2004;22:1807–14.PubMedCrossRef
23.
go back to reference Kim NW, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011.PubMedCrossRef Kim NW, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011.PubMedCrossRef
Metadata
Title
Telomere shortening occurs early during gastrocarcinogenesis
Authors
Yunchuan Mu
Qing Zhang
Linhang Mei
Xiaosun Liu
Weili Yang
Jiren Yu
Publication date
01-06-2012
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2012
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-011-9866-3

Other articles of this Issue 2/2012

Medical Oncology 2/2012 Go to the issue

Letter to the Editor

Pseudolymphoma of the orbit

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.